We use cookies for a better user experience. Read our Privacy Policy

I Agree

Industry Verticals »

All Categories

Insights »

About TMR »

Anti-infective Drugs Market

Schedule a Call

Anti-infective Drugs Market

Anti-infective Drugs Market (Type - Anti-bacterial Drugs (B-lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside, Others (Sulfonamide, Phenicols)), Anti-fungal Drugs (Azoles, Echinocandins, Polyenes), Anti-viral Drugs; Indication - Pneumonia, Methicillin-resistant Staphylococcus Aureus (MRSA), Sepsis, Tuberculosis, Dermatophytosis, Aspergillosis, Candidiasis, Hepatitis Virus Infection, HIV Infection, Respiratory Virus Infection; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025

Anti-infective Drugs Market: Snapshot

The global anti-infective drugs market is driven by increase in prevalence of infectious diseases across the globe. The global market was valued at US$ 106.5 Bn in 2016 and is projected to expand at a CAGR of 4.2% from 2017 to 2025 to reach US$ 153.3 Bn by 2025. Growth of the market is attributed to increase in digitization of dental practices, high health care IT budgets, and rise in demand for chair time optimization in developed markets.

global anti infective drugs market

Anti-infective drugs are used for the purpose of killing and/or suppressing the infection causing organisms from invading the host organism by means of replication or releasing variety of toxins in the host. Such infection causing micro-organisms include viruses, bacteria, fungi, viroids, and macro parasites. Infections thus caused can be classified depending on the type of organism causing infection and the symptoms and medical signs shown by host. High prevalence and incidence rates of infectious diseases, especially viral infection, and newer drug introductions have resulted in increase in growth of global anti-infective drugs market. These factors are projected to drive demand for anti-infective drugs in the near future. Moreover, rapidly growing antibacterial resistance and unmet medical needs within antiviral therapy are expected to fuel the growth of the anti-infective drugs market.

Anti-infective Drugs Market: Segmentation

The global anti-infective drugs market has been segmented based on type, indication, distribution channel, and region. In terms of type, the global market has been categorized into anti-bacterial drugs, anti-fungal drugs, and anti-viral drugs. The anti-viral drugs segment accounted for significant share of the global market in terms of revenue in 2016. The segment is expected to expand at a rapid pace during the forecast period. It is likely to gain market share by the end of 2025. This is attributed to increase in prevalence of viral infection, especially HIV infection, hepatitis virus infection, and others.

In terms of indication, the global anti-infective drugs market has been classified into pneumonia, methicillin-resistant Staphylococcus aureus (MRSA), sepsis, tuberculosis, dermatophytosis, aspergillosis, candidiasis, hepatitis virus infection, HIV infection, respiratory virus infection, and others. The HIV infection segment dominated the global market and the trend is likely to continue by the end of 2025 with marginal increase in market share. The HIV infection segment is projected to dominate the global anti-infective drugs market as these drugs are administered to patients for the lifetime and new and effective treatments are being introduced. Based on distribution channel, the global market has been divided into hospital pharmacy, retail pharmacy and online pharmacy. 

Geographically, the global anti-infective drugs market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market and is projected to lose market share by the end of 2025. The region’s dominance of the global anti-infective drugs market is due to factors such as increase in adoption of advanced and high cost drug therapies and significant treatment penetration. Moreover, patients with HIV infection and hepatitis virus infection have increased in the U.S. This is projected to fuel the growth of the anti-infective drugs market in the country during the forecast period. Asia Pacific is projected to be the fastest growing market for anti-infective drugs during the forecast period. India dominated the anti-infective drugs market in the region, whereas Japan is estimated to grow at a high CAGR during the forecast period.

Key players in the global anti-infective drugs market include Merck & Co., Inc., Bayer AG, Pfizer, Inc., Gilead Sciences, GlaxoSmithKline plc, Novartis AG, Bristol-Myers Squibb, Sanofi, Allergen plc, F. Hoffman-La Roche Ltd., and Johnson and Johnson. Companies are adopting the strategy acquisition and collaboration to improve and strengthen geographic presence.

The global anti-infective drugs market has been segmented as follows:

by Type
  • Anti-bacterial Drugs
    • B-lactams
    • Quinolones
    • Macrolides
    • Tetracycline
    • Aminoglycoside
    • Others (sulfonamide, phenicols)
  • Anti-fungal Drugs
    • Azoles
    • Echinocandins
    • Polyenes
    • Others
  • Anti-viral Drugs

by Indication
  • Pneumonia
  • Methicillin-resistant Staphylococcus Aureus (MRSA)
  • Sepsis
  • Tuberculosis
  • Dermatophytosis
  • Aspergillosis
  • Candidiasis
  • Hepatitis Virus Infection
  • HIV Infection
  • Respiratory Virus Infection
  • Others

by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales

by Region
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa


    1. Preface
         1.1. Report Scope and Market Segmentation
         1.2. Research Highlights

    2. Assumptions and Research Methodology
         2.1. Assumptions
         2.2. Acronyms Used
         2.3. Research Methodology

    3. Executive Summary
         3.1. Global Anti-infective Drugs Market Snapshot
         3.2. Market Opportunity Map

    4. Market Overview
         4.1. Product Overview
         4.2. Global Anti-infective Drugs Market Size (US$ Mn) Forecast, 2017–2025
         4.3. Global Anti-infective Drugs Market Outlook
         4.4. Key Industry Developments

    5. Market Dynamics
         5.1. Drivers and Restraints Snapshot Analysis
         5.2. Drivers
         5.3. Restraints
         5.4. Opportunities
         5.5. Key Trends
         5.6. Porter’s Analysis
         5.7. Pipeline Analysis
         5.8. Disease Prevalence
         5.9. Key Brand Analysis

    6. Global Anti-infective Drugs Market Analysis, by Type
         6.1. Key Findings
         6.2. Introduction
         6.3. Anti-infective Drugs Market Value Share Analysis, by Type
         6.4. Anti-infective Drugs Market Forecast, by Type
               6.4.1. Global Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
                         6.4.1.1. B - Lactams
                         6.4.1.2. Quinolones
                         6.4.1.3. Macrolides
                         6.4.1.4. Tetracycline
                         6.4.1.5. Aminoglycoside
                         6.4.1.6. Others (Sulfonamide, Phenicols)
               6.4.2. Global Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
                         6.4.2.1. Azoles
                         6.4.2.2. Echinocandins
                         6.4.2.3. Polyenes
                         6.4.2.4. Others
               6.4.3. Global Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
         6.5. Anti-infective Drugs Market Analysis, by Type
         6.6. Anti-infective Drugs Market Attractiveness Analysis, by Type
         6.7. Market Trends

    7. Anti-infective Drugs Market Analysis, by Disease Indication
         7.1. Key Findings
         7.2. Introduction
         7.3. Anti-infective Drugs Market Value Share Analysis, by Disease Indication
         7.4. Anti-infective Drugs Market Forecast, by Disease Indication
               7.4.1. Pneumonia
               7.4.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
               7.4.3. Sepsis
               7.4.4. Tuberculosis
               7.4.5. Dermatophytosis
               7.4.6. Aspergillosis
               7.4.7. Candidiasis
               7.4.8. Hepatitis Virus Infection
               7.4.9. HIV Infection
               7.4.10. Respiratory Virus Infection
               7.4.11. Others
         7.5. Anti-infective Drugs Market Analysis, by Disease Indication
         7.6. Anti-infective Drugs Market Attractiveness Analysis, by Disease Indication
         7.7. Key Trends

    8. Anti-infective Drugs Market Analysis, by Distribution Channel
         8.1. Key Findings
         8.2. Introduction
         8.3. Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
         8.4. Anti-infective Drugs Market Forecast, by Distribution Channel
               8.4.1. Hospital Pharmacy
               8.4.2. Retail Pharmacy
               8.4.3. Online Sales
         8.5. Anti-infective Drugs Market Analysis, by Distribution Channel
         8.6. Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel
         8.7. Market Trends

    9. Anti-infective Drugs Market Analysis, by Region
         9.1. Global Market Scenario
         9.2. Anti-infective Drugs Market Value Share Analysis, by Region
         9.3. Anti-infective Drugs Market Forecast, by Region
               9.3.1. North America
               9.3.2. Europe
               9.3.3. Asia Pacific
               9.3.4. Latin America
               9.3.5. Middle East & Africa
         9.4. Anti-infective Drugs Market Attractiveness Analysis, by Region

    10. North America Anti-infective Drugs Market Analysis
         10.1. Key Findings
         10.2. North America Anti-infective Drugs Market Overview
         10.3. North America Anti-infective Drugs Market Value Share Analysis, by Country
         10.4. North America Anti-infective Drugs Market Forecast, by Country
               10.4.1. U.S.
               10.4.2. Canada
         10.5. North America Anti-infective Drugs Market Value Share Analysis, by Type
         10.6. North America Anti-infective Drugs Market Forecast, by Type
               10.6.1. North America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
               10.6.2. North America Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
                         10.6.2.1. B - Lactams
                         10.6.2.2. Quinolones
                         10.6.2.3. Macrolides
                         10.6.2.4. Tetracycline
                         10.6.2.5. Aminoglycoside
                         10.6.2.6. Others (Sulfonamide, Phenicols)
               10.6.3. North America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
               10.6.4. North America Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
                         10.6.4.1. Azoles
                         10.6.4.2. Echinocandins
                         10.6.4.3. Polyenes
                         10.6.4.4. Others
               10.6.5. North America Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
         10.7. North America Anti-infective Drugs Market Value Share Analysis, by Indication
         10.8. North America Anti-infective Drugs Market Forecast, by Indication
               10.8.1. Pneumonia
               10.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
               10.8.3. Sepsis
               10.8.4. Tuberculosis
               10.8.5. Dermatophytosis
               10.8.6. Aspergillosis
               10.8.7. Candidiasis
               10.8.8. Hepatitis Virus Infection
               10.8.9. HIV Infection
               10.8.10. Respiratory Virus Infection
               10.8.11. Others
         10.9. North America Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
         10.10. North America Anti-infective Drugs Market Forecast, by Distribution Channel
               10.10.1. Hospital Pharmacy
               10.10.2. Retail Pharmacy
               10.10.3. Online Sales
         10.11. North America Anti-infective Drugs Market Attractiveness Analysis

    11. Europe Anti-infective Drugs Market Analysis
         11.1. Key Findings
         11.2. Europe Anti-infective Drugs Market Overview
         11.3. Europe Anti-infective Drugs Market Value Share Analysis, by Country
         11.4. Europe Anti-infective Drugs Market Forecast, by Country
               11.4.1. U.K.
               11.4.2. Germany
               11.4.3. France
               11.4.4. Italy
               11.4.5. Spain
               11.4.6. Rest of Europe
         11.5. Europe Anti-infective Drugs Market Value Share Analysis, by Type
         11.6. Europe Anti-infective Drugs Market Forecast, by Type
               11.6.1. Europe Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
               11.6.2. Europe Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
                         11.6.2.1. B - Lactams
                         11.6.2.2. Quinolones
                         11.6.2.3. Macrolides
                         11.6.2.4. Tetracycline
                         11.6.2.5. Aminoglycoside
                         11.6.2.6. Others (Sulfonamide, Phenicols)
               11.6.3. Europe Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
               11.6.4. Europe Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
                         11.6.4.1. Azoles
                         11.6.4.2. Echinocandins
                         11.6.4.3. Polyenes
                         11.6.4.4. Others
               11.6.5.  Europe Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
         11.7. Europe Anti-infective Drugs Market Value Share Analysis, by Indication
         11.8. Europe Anti-infective Drugs Market Forecast, by Indication
               11.8.1. Pneumonia
               11.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
               11.8.3. Sepsis
               11.8.4. Tuberculosis
               11.8.5. Dermatophytosis
               11.8.6. Aspergillosis
               11.8.7. Candidiasis
               11.8.8. Hepatitis Virus Infection
               11.8.9. HIV Infection
               11.8.10. Respiratory Virus Infection
               11.8.11. Others
         11.9. Europe Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
         11.10. Europe Anti-infective Drugs Market Forecast, by Distribution Channel
               11.10.1. Hospital Pharmacy
               11.10.2. Retail Pharmacy
               11.10.3. Online Sales
         11.11. Europe Anti-infective Drugs Market Attractiveness Analysis

    12. Asia Pacific Anti-infective Drugs Market Analysis
         12.1. Key Findings
         12.2. Asia Pacific Anti-infective Drugs Market Overview
         12.3. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Country
         12.4. Asia Pacific rope Anti-infective Drugs Market Forecast, by Country
               12.4.1. China
               12.4.2. Japan
               12.4.3. India
               12.4.4. Australia & New Zealand
               12.4.5. Rest of APAC
         12.5. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type
         12.6. Asia Pacific Anti-infective Drugs Market Forecast, by Type
               12.6.1. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
               12.6.2. Asia Pacific Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
                         12.6.2.1. B - Lactams
                         12.6.2.2. Quinolones
                         12.6.2.3. Macrolides
                         12.6.2.4. Tetracycline
                         12.6.2.5. Aminoglycoside
                         12.6.2.6. Others (Sulfonamide, Phenicols)
               12.6.3. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
               12.6.4. Asia Pacific Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
                         12.6.4.1. Azoles
                         12.6.4.2. Echinocandins
                         12.6.4.3. Polyenes
                         12.6.4.4. Others
               12.6.5.  Asia Pacific Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
         12.7. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Indication
         12.8. Asia Pacific Anti-infective Drugs Market Forecast, by Indication
               12.8.1. Pneumonia
               12.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
               12.8.3. Sepsis
               12.8.4. Tuberculosis
               12.8.5. Dermatophytosis
               12.8.6. Aspergillosis
               12.8.7. Candidiasis
               12.8.8. Hepatitis Virus Infection
               12.8.9. HIV Infection
               12.8.10. Respiratory Virus Infection
               12.8.11. Others
         12.9. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
         12.10. Asia Pacific Anti-infective Drugs Market Forecast, by Distribution Channel
               12.10.1. Hospital Pharmacy
               12.10.2. Retail Pharmacy
               12.10.3. Online Sales
         12.11. Asia Pacific Anti-infective Drugs Market Attractiveness Analysis

    13. Latin America Anti-infective Drugs Market Analysis
         13.1. Key Findings
         13.2. Latin America Anti-infective Drugs Market Overview
         13.3. Latin America Anti-infective Drugs Market Value Share Analysis, by Country
         13.4. Latin America Anti-infective Drugs Market Forecast, by Country
               13.4.1. Brazil
               13.4.2. Mexico
               13.4.3. Rest of LATAM
         13.5. Latin America Anti-infective Drugs Market Value Share Analysis, by Type
         13.6. Latin America Anti-infective Drugs Market Forecast, by Type
               13.6.1. Latin America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
               13.6.2. Latin America Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
                         13.6.2.1. B - Lactams
                         13.6.2.2. Quinolones
                         13.6.2.3. Macrolides
                         13.6.2.4. Tetracycline
                         13.6.2.5. Aminoglycoside
                         13.6.2.6. Others (Sulfonamide, Phenicols)
               13.6.3. Latin America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
               13.6.4. Latin America Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
                         13.6.4.1. Azoles
                         13.6.4.2. Echinocandins
                         13.6.4.3. Polyenes
                         13.6.4.4. Others
               13.6.5.  Latin America Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
         13.7. Latin America Anti-infective Drugs Market Value Share Analysis, by Indication
         13.8. Latin America Anti-infective Drugs Market Forecast, by Indication
               13.8.1. Pneumonia
               13.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
               13.8.3. Sepsis
               13.8.4. Tuberculosis
               13.8.5. Dermatophytosis
               13.8.6. Aspergillosis
               13.8.7. Candidiasis
               13.8.8. Hepatitis Virus Infection
               13.8.9. HIV Infection
               13.8.10. Respiratory Virus Infection
               13.8.11. Others
         13.9. Latin America Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
         13.10. Latin America Anti-infective Drugs Market Forecast, by Distribution Channel
               13.10.1. Hospital Pharmacy
               13.10.2. Retail Pharmacy
               13.10.3. Online Sales
         13.11. Latin America Anti-infective Drugs Market Attractiveness Analysis

    14. Middle East & Africa Anti-infective Drugs Market Analysis
         14.1. Key Findings
         14.2. Middle East & Africa Anti-infective Drugs Market Overview
         14.3. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Country
         14.4. Middle East & Africa Anti-infective Drugs Market Forecast, by Country
               14.4.1. GCC Countries
               14.4.2. South Africa
               14.4.3. Rest of MEA
         14.5. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type
         14.6. Middle East & Africa Anti-infective Drugs Market Forecast, by Type
               14.6.1. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
               14.6.2. Middle East & Africa Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
                         14.6.2.1. B - Lactams
                         14.6.2.2. Quinolones
                         14.6.2.3. Macrolides
                         14.6.2.4. Tetracycline
                         14.6.2.5. Aminoglycoside
                         14.6.2.6. Others (Sulfonamide, Phenicols)
               14.6.3. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
               14.6.4. Middle East & Africa Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
                         14.6.4.1. Azoles
                         14.6.4.2. Echinocandins
                         14.6.4.3. Polyenes
                         14.6.4.4. Others
               14.6.5.  Middle East & Africa Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
         14.7. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Indication
         14.8. Middle East & Africa Anti-infective Drugs Market Forecast, by Indication
               14.8.1. Pneumonia
               14.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
               14.8.3. Sepsis
               14.8.4. Tuberculosis
               14.8.5. Dermatophytosis
               14.8.6. Aspergillosis
               14.8.7. Candidiasis
               14.8.8. Hepatitis Virus Infection
               14.8.9. HIV Infection
               14.8.10. Respiratory Virus Infection
               14.8.11. Others
         14.9. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
               14.9.1. Hospital Pharmacy
               14.9.2. Retail Pharmacy
               14.9.3. Online Sales
         14.10. Middle East & Africa Anti-infective Drugs Market Forecast, by Distribution Channel
         14.11. Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis

    15. Competition Matrix
         15.1. Anti-infective Drugs Market Share Analysis, by Company, 2016
         15.2. Company Profiles
               15.2.1. Merck & Co., Inc.
                         15.2.1.1. Company Profiles
                         15.2.1.2. Business Overview
                         15.2.1.3. Strategic Overview
                         15.2.1.4. SWOT Analysis
         15.3. Bayer AG
                         15.3.1.1. Company Profiles
                         15.3.1.2. Business Overview
                         15.3.1.3. Strategic Overview
                         15.3.1.4. SWOT Analysis
         15.4. Pfizer, Inc.
                         15.4.1.1. Company Profiles
                         15.4.1.2. Business Overview
                         15.4.1.3. Strategic Overview
                         15.4.1.4. SWOT Analysis
         15.5. Gilead Sciences
                         15.5.1.1. Company Profiles
                         15.5.1.2. Business Overview
                         15.5.1.3. Strategic Overview
                         15.5.1.4. SWOT Analysis
         15.6. GlaxoSmithKline plc
                         15.6.1.1. Company Profiles
                         15.6.1.2. Business Overview
                         15.6.1.3. Strategic Overview
                         15.6.1.4. SWOT Analysis
         15.7. Novartis AG
                         15.7.1.1. Company Profiles
                         15.7.1.2. Business Overview
                         15.7.1.3. Strategic Overview
                         15.7.1.4. SWOT Analysis
         15.8. Bristol-Myers Squibb Co
                         15.8.1.1. Company Profiles
                         15.8.1.2. Business Overview
                         15.8.1.3. Strategic Overview
                         15.8.1.4. SWOT Analysis
         15.9. Sanofi
                         15.9.1.1. Company Profiles
                         15.9.1.2. Business Overview
                         15.9.1.3. Strategic Overview
                         15.9.1.4. SWOT Analysis
         15.10. Allergen plc
                         15.10.1.1. Company Profiles
                         15.10.1.2. Business Overview
                         15.10.1.3. Strategic Overview
                         15.10.1.4. SWOT Analysis
         15.11. F. Hoffman-La Roche Ltd.
                         15.11.1.1. Company Profiles
                         15.11.1.2. Business Overview
                         15.11.1.3. Strategic Overview
                         15.11.1.4. SWOT Analysis
         15.12. Johnson and Johnson
                         15.12.1.1. Company Profiles
                         15.12.1.2. Business Overview
                         15.12.1.3. Strategic Overview
                         15.12.1.4. SWOT Analysis

     

    List of Tables

    Table 01: Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
    Table 02: Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
    Table 03: Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
    Table 04: Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Disease Indication, 2017–2025
    Table 05: Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
    Table 06: Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Region, 2017–2025
    Table 07: North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
    Table 08: North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
    Table 09: North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
    Table 10: North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
    Table 10: North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
    Table 12: North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
    Table 13: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
    Table 14: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
    Table 15: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
    Table 16: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
    Table 17: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
    Table 18: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
    Table 19: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
    Table 20: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
    Table 21: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
    Table 22: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
    Table 23: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
    Table 24: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
    Table 25: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
    Table 26: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
    Table 27: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
    Table 28: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
    Table 29: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
    Table 30: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
    Table 31: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
    Table 32: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
    Table 33: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
    Table 34: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
    Table 35: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
    Table 36: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025

     

    List of Figures

    Figure 01: Global Anti-infective Drugs Market Snapshot
    Figure 02: Global Antiviral Drugs Market Size (US$ Mn) Forecast, 2017–2025
    Figure 04: Market Value Share, by Type (2016)
    Figure 06: Market Value Share, by Distribution Channel (2016)
    Figure 03: Market Value Share, by Disease Indication (2016)
    Figure 05: Market Value Share, by Region (2016)
    Figure 07: Leading Antibacterial Drugs Sales Analysis, 2014–2016 
    Figure 08: Leading Antiviral Drugs Sales Analysis, 2014–2016 
    Figure 09: Global Anti-infective Drugs Market Value Share, by Product, 2016 and 2025
    Figure 10: Global Anti-bacterial Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 10: Global Anti-fungal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 12: Global Anti-viral Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 13: Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
    Figure 14: Global Anti-infective Drugs Market Value Share, by Disease Indication, 2016 and 2025
    Figure 15: Global Pneumonia - Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 16: Global Methicillin-resistant Staphylococcus Aureus (MRSA) - Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 17: Global Sepsis Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 18: Global Tuberculosis Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 19: Global Dermatophytosis- Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 20: Global Aspergillosis -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 21: Global Candidiasis -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 22: Global Hepatitis Virus Infection -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 23: Global HIV Infection -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 24: Global Respiratory Virus Infection -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 25: Global Others-Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 26: Anti-infective Drugs Market Attractiveness Analysis, by Disease Indication, 2017–2025
    Figure 27: Global Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
    Figure 28: Global Hospital Pharmacy Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 29: Global Retail Pharmacy Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 30: Global Online Pharmacy Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 31: Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
    Figure 32: Global Anti-infective Drugs Market Value Share, by Region, 2016 and 2025
    Figure 33: Anti-infective Drugs Market Attractiveness Analysis, by Region, 2017–2025
    Figure 34: North America Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
    Figure 35: North America Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
    Figure 36: North America Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
    Figure 37: North America Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
    Figure 38: North America Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
    Figure 39: North America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
    Figure 40: North America Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
    Figure 41: North America Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
    Figure 42: North America Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
    Figure 43: North America Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2017–2025
    Figure 44: North America Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
    Figure 45: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
    Figure 46: Europe Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
    Figure 47: Europe Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
    Figure 48: Europe Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
    Figure 49: Europe Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
    Figure 50: Europe Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
    Figure 51: Europe Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
    Figure 52: Europe Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
    Figure 53: Europe Anti-infective Drugs Market Attractiveness Analysis, by Type, 2016–2025
    Figure 54: Europe Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2016–2025
    Figure 55: Europe Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2016–2025
    Figure 56: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
    Figure 57: Asia Pacific Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
    Figure 58: Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
    Figure 59: Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
    Figure 60: Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
    Figure 61: Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
    Figure 62: Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
    Figure 63: Asia Pacific Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
    Figure 64: Asia Pacific Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
    Figure 65: Asia Pacific Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2017–2025
    Figure 66: Asia Pacific Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
    Figure 67: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
    Figure 68: Latin America Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
    Figure 69: Latin America Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
    Figure 70: Latin America Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
    Figure 71: Latin America Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
    Figure 72: Latin America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
    Figure 73: Latin America Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
    Figure 74: Latin America Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2024
    Figure 75: Latin America Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
    Figure 76: Latin America Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2017–2025
    Figure 77: Latin America Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2016–2024
    Figure 78: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
    Figure 79: Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
    Figure 80: Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
    Figure 81: Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
    Figure 82: Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
    Figure 83: Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
    Figure highlights market value share of the Anti-infective Drugs Market in Middle East & Africa, by Type –anti-fungal drugs, for 2016 and 2025
    Figure 84: Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
    Figure 85: Middle East & Africa Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
    Figure 86: Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
    Figure 87: Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2017–2025
    Figure 88: Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025

     

Copyright © Transparency Market Research, Inc. All Rights reserved